Compare
Charming Medical Ltd vs Pacific Health Care Organization Inc vs Cryo Cell International Inc vs BioRestorative Therapies, Inc.
| Latest fiscal year | Charming Medical Ltd MCTA | Pacific Health Care Organization Inc PFHO | Cryo Cell International Inc CCEL | BioRestorative Therapies, Inc. BRTX |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-11-30 | 2025-12-31 |
| Revenue | $4.81M | $6.72M | $31.57M | $359.7K |
| Revenue growth (YoY) | -22.7% | +10.7% | -1.3% | -10.3% |
| Gross margin | n/a | n/a | 76.6% (computed) | 93.4% |
| Operating margin | -0.6% | 14.9% | 1.5% | n/m |
| Net margin | -0.5% | 20.7% | -7.7% | n/m |
| Net income | -$22.6K | $1.39M | -$2.43M | -$14.24M |
| EPS (Diluted) | $0.00 | $0.11 | -$0.30 | -$1.58 |
| Operating cash flow | -$1.22M | $1.16M | $5.48M | -$10.79M |
| Free cash flow | -$1.56M | $1.14M | $5.25M | -$10.91M |
| Cash & equivalents | $4.70M | $2.17M | $319.0K | $1.51M |
| Total assets | $9.87M | $13.46M | $61.73M | $4.08M |
| Total liabilities | $4.69M | n/a | $80.33M | n/a |
| Shareholders' equity | $5.18M | $13.07M | -$18.61M | $356.7K |
| Return on year-end equity | -0.4% | 10.6% | n/a | n/m |
| Shares outstanding | n/a | 12.80M | 8.06M | 8.88M |
Revenue, most recent five fiscal years
| Fiscal year | Charming Medical Ltd | Pacific Health Care Organization Inc | Cryo Cell International Inc | BioRestorative Therapies, Inc. |
|---|---|---|---|---|
| Latest | $4.81M Ended 2026-03-31 | $6.72M Ended 2025-12-31 | $31.57M Ended 2025-11-30 | $359.7K Ended 2025-12-31 |
| 1 year earlier | $6.22M Ended 2025-03-31 | $6.07M Ended 2024-12-31 | $31.99M Ended 2024-11-30 | $401.0K Ended 2024-12-31 |
| 2 years earlier | $6.02M Ended 2024-03-31 | $5.63M Ended 2023-12-31 | $31.34M Ended 2023-11-30 | $145.8K Ended 2023-12-31 |
| 3 years earlier | n/a | $5.74M Ended 2022-12-31 | $30.34M Ended 2022-11-30 | $119.8K Ended 2022-12-31 |
| 4 years earlier | n/a | $5.40M Ended 2021-12-31 | $28.88M Ended 2021-11-30 | $46.0K Ended 2021-12-31 |